When the Wire Doesn't Come Out Authors: Pankaj Garg Published: 2026 ABSTRACT Corresponding AuthorKey Words: cardiac pacemaker, cardiovascular disease, complication, coronary artery bypass, imaging, left ventricle, myocardial ischemia, right ventricle, secondary prevention Temporary epicardial pacing wires (TEPWs) are routinely placed after cardiac surgery and removed at the bedside a few days after surgery. When the wire removal fails, standard practice is to cut the wire flush with the skin. Some surgeons prefer to electively cut the wire instead of removing them. For most patients, retained pieces of wire remain inconsequential. Rarely, the retained piece of TEPW migrates from the epicardial surface and the consequences can be catastrophic. The case reported by Shah et al1 in this issue is neither typical nor catastrophic. It is rare that a retained wire traverses the atrial septum, crosses the mitral valve, and lodges in the left ventricle over the course of 24 years, entirely without symptoms. This case is exceptional on 2 counts. First, left-sided migration of TEPW is rare and nearly all reported cases involved aortic or carotid artery migration. Further, most left-sided migration of TEPWs were complicated by infection.2 The present patient had neither. Second, the transatrial septal trajectory of the wire has never been previously described,3 and its mechanism remains genuinely unclear. The authors' acknowledgment of this honestly rather than speculating is the strength of this report. The Case for Conservative Management Given the rarity of the scenario and absence of guidelines for the management of an asymptomatic, incidentally discovered migrated TEPW in the left heart, the treating team's decision to forgo retrieval of the TEPW is defensible. The patient was 81 years old with prior coronary artery bypass grafting with stented graft disease, ischemic cardiomyopathy, and reduced ejection fraction. The wire had caused no harm for more than 2 decades. Further, the risk of open surgical removal substantially exceeded any plausible benefit. The prior report by Tipton et al4 of conservative management of a wire eroding into an aortic aneurysm—with antithrombotic therapy and surveillance—offered a limited but useful precedent. The anticoagulation strategy in this situation also deserves a brief comment. Apixaban initiation to reduce the thromboembolic risk from intracardiac TEPW was pharmacologically sound. Further, its early discontinuation due to gastrointestinal bleeding, and the return to dual antiplatelet therapy, was a pragmatic compromise. Whether aspirin and clopidogrel provide equivalent protection against left-sided cardiac thrombus in this context is uncertain. Future cases should anticipate this problem of gastrointestinal bleeding and consider early gastroenterology involvement or alternative anticoagulation strategies. What This Case Should Change Three practical lessons emerge. First, retained TEPWs and their site must be clearly documented in the discharge note and clearly communicated to the patient and the future provider. In this case, the wire went unrecognized for 24 years across multiple clinical encounters culminating in serious potential consequences. Second, when a retained TEPW is discovered, management requires multidisciplinary discussion with cardiac surgery, cardiology, intervention cardiology, and where relevant, vascular surgery. Third, surveillance should be long term, structured, and prospective. In the absence of formal guidelines, the authors’ proposal of 6-monthly echocardiography with defined triggers for intervention (new endocarditis, progressive migration of the wire, heart failure, cerebrovascular events) is a reasonable prototype for future cases. A final observation. The authors note that the principle of “less is more” has not been embraced in cardiology to the same extent as in other specialties. This case, in its quiet 24-year arc from coronary artery bypass grafting to incidental discovery of TEPW in the left ventricle to uneventful 1-year follow-up, is a small contribution toward that evidence base. Although triggers for intervention listed by the authors are real and must be respected, it does not prove that conservative management is always appropriate. This case demonstrates that the mere presence of a metallic foreign body in the left heart, in an asymptomatic patient, is not in itself an indication for a trip to the operating room.5 Sometimes the most considered clinical decision is restraint. Funding Support and Author Disclosures The author has reported that he has no relationships relevant to the contents of this paper to disclose. Footnotes The author attests they are in compliance with human studies committees and animal welfare regulations of the author’s institution and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center. References